We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$484M
AUM Growth
+$36.9M
Cap. Flow
+$6.09M
Cap. Flow %
1.26%
Top 10 Hldgs %
26.56%
Holding
273
New
13
Increased
78
Reduced
63
Closed
4

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$973K
2
WY icon
Weyerhaeuser
WY
+$638K
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$453K
4
AIG icon
American International
AIG
+$430K
5
VNO icon
Vornado Realty Trust
VNO
+$423K

Top Sells

Rank Stock Value
1
NWSA
NEWS CORPORATION CL-A
NWSA
+$326K
2
SRPT icon
Sarepta Therapeutics
SRPT
+$272K
3
CP icon
Canadian Pacific Kansas City
CP
+$231K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$224K
5
AMGN icon
Amgen
AMGN
+$169K

Sector Composition

Rank Sector Weight
1 Healthcare 22.9%
2 Industrials 12.46%
3 Consumer Staples 12.36%
4 Energy 9.49%
5 Technology 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNY icon
201
Sanofi
SNY
$103B
$362K 0.07%
7,142
+500
+8% +$25.4K
FFIV icon
202
F5
FFIV
$22.1B
$358K 0.07%
4,170
– –
UNP icon
203
Union Pacific
UNP
$172B
$358K 0.07%
4,614
+1,000
+28% +$79K
DE icon
204
Deere & Co
DE
$162B
$356K 0.07%
4,373
– –
SO icon
205
Southern Company
SO
$106B
$356K 0.07%
8,650
– –
MCD icon
206
McDonald's
MCD
$191B
$354K 0.07%
3,680
+500
+16% +$48.8K
VIG icon
207
Vanguard Dividend Appreciation ETF
VIG
$112B
$348K 0.07%
5,007
+2
+0% +$138
AFL icon
208
Aflac
AFL
$64.8B
$346K 0.07%
11,168
– –
MDT icon
209
Medtronic
MDT
$110B
$346K 0.07%
6,500
– –
SLV icon
210
iShares Silver Trust
SLV
$28.6B
$343K 0.07%
16,415
+1,860
+13% +$38.4K
NOV icon
211
NOV
NOV
$6.93B
$336K 0.07%
4,769
– –
CLF icon
212
Cleveland-Cliffs
CLF
$6.64B
$334K 0.07%
16,311
+5
+0% +$103
CIEN icon
213
Ciena
CIEN
$52.7B
$329K 0.07%
13,142
– –
VBR icon
214
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.2B
$329K 0.07%
3,649
-169
-4% -$15K
BANF icon
215
BancFirst
BANF
$3.77B
$324K 0.07%
12,000
– –
JJSF icon
216
J&J Snack Foods
JJSF
$1.44B
$323K 0.07%
4,000
– –
RVBD
217
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
$309K 0.06%
21,150
-4,600
-18% -$73.6K
CPN
218
DELISTED
Calpine Corporation
CPN
$305K 0.06%
+15,700
New +$311K
HUSI.PRG
219
DELISTED
HSBC USA INC DEP SHS REPSTG 1/40 PRD SER G
HUSI.PRG
$300K 0.06%
14,400
+250
+2% +$5.6K
RDS.A
220
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$298K 0.06%
4,538
– –
LCC
221
DELISTED
US AIRWAYS GROUP INC.
LCC
$297K 0.06%
15,660
+2,910
+23% +$51.5K
HOT
222
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$296K 0.06%
+4,451
New +$295K
SBR
223
Sabine Royalty Trust
SBR
$1.06B
$295K 0.06%
5,800
– –
IMVP
224
Invesco India ETF
IMVP
$125M
$294K 0.06%
18,380
+1,100
+6% +$17.7K
TGT icon
225
Target
TGT
$65.6B
$294K 0.06%
4,591
+50
+1% +$3.4K
7 8
9
10 11

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Gerald L. Ray & Associates held 273 positions worth $484M, up 8.3% from $447M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Gerald L. Ray & Associates's Q3 2013 filing shows 13 new, 78 increased, 63 reduced and 4 closed positions. Its largest new stake was Acadia Pharmaceuticals: 46,550 shares worth $1.28M. The largest sale was NEWS CORPORATION CL-A, an estimated $326K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q3 2013 buy was Acadia Pharmaceuticals: 46,550 shares worth $1.28M.
  • Gerald L. Ray & Associates added most to American International in Q3 2013, an estimated $430K increase.
  • Gerald L. Ray & Associates's biggest Q3 2013 reduction was Regeneron Pharmaceuticals, cutting an estimated $224K.
  • Gerald L. Ray & Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $326K.
  • Gerald L. Ray & Associates's ten largest holdings make up 27% of its $484M portfolio in Q3 2013.
  • Gerald L. Ray & Associates opened 13 new positions and closed 4 in Q3 2013.
  • Gerald L. Ray & Associates's portfolio value rose 8.3% quarter-over-quarter to $484M.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2013, filed 5 Nov 2013.